Aortic Stenosis and Heart Failure: Disease Ascertainment and Statistical Considerations for Clinical Trials
Author(s) -
Ernest Spitzer,
Rebecca T. Hahn,
Philippe Pîbarot,
Ton de Vries,
Jeroen J. Bax,
Martin B. Leon,
Nicolas M. Van Mieghem
Publication year - 2019
Publication title -
cardiac failure review
Language(s) - English
Resource type - Journals
eISSN - 2057-7559
pISSN - 2057-7540
DOI - 10.15420/cfr.2018.41.2
Subject(s) - medicine , stenosis , heart failure , clinical trial , disease , quality of life (healthcare) , heart disease , aortic valve stenosis , cardiology , intensive care medicine , nursing
Aortic stenosis is a progressive disease that develops over decades, and once symptomatic and untreated, is associated with poor survival. Transcatheter aortic valve replacement has evolved significantly in the past decade and has expanded its indication from surgically inoperable and high-risk patients to patients with intermediate risk. Assessment of heart failure-related outcomes include the use of functional assessments, disease-specific quality of life surveys and standardised ascertainment of events, such as hospitalisations. Multiple statistical approaches are currently being tested to account for recurrent events such as hospitalisations for heart failure or to combine binary and continuous outcomes, both intended to assess the holistic burden of the disease, as opposed to the traditional analysis of time to first event.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom